Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7208146rdf:typepubmed:Citationlld:pubmed
pubmed-article:7208146lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:7208146lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:7208146lifeskim:mentionsumls-concept:C0520572lld:lifeskim
pubmed-article:7208146lifeskim:mentionsumls-concept:C0597619lld:lifeskim
pubmed-article:7208146lifeskim:mentionsumls-concept:C2673735lld:lifeskim
pubmed-article:7208146lifeskim:mentionsumls-concept:C1291208lld:lifeskim
pubmed-article:7208146pubmed:issue12lld:pubmed
pubmed-article:7208146pubmed:dateCreated1981-5-21lld:pubmed
pubmed-article:7208146pubmed:abstractTextMetabolic observations during early stages of hyperammonemia in two infants with ornithine transcarbamylase deficiency suggest that plasma alpha-ketoglutarate concentration ([alpha-KG]) becomes subnormal before the development of hyperammonemic coma. In one case, plasma [NH4+] remained normal until 40 days of age when it rose to 58 microM. However, this hyperammonemia was preceded by a fall in plasma [alpha-KG] to 15 microM at 27 days of age. It was only after severe hyperammonemia was established at 50 days of age that coma supervened. In the second case, plasma [alpha-KG] became subnormal (14 microM) 8 days before the rise in plasma ammonium concentration [NH4+] (52 microM) and 14 days before the onset of hyperammonemic coma. In eight patients with urea cycle enzymopathies, there was a highly significant (P less than 0.01) negative linear correlation between [NH4+] and [alpha-KG]. In patients with portal-systemic encephalopathy, there was a similar relationship between [NH4+] and [alpha-KG], although the absolute [alpha-KG] levels in these patients were normal (23 +/- 4 microM) while the patients were hyperammonemic (88 +/- 25 microM).lld:pubmed
pubmed-article:7208146pubmed:languageenglld:pubmed
pubmed-article:7208146pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7208146pubmed:citationSubsetIMlld:pubmed
pubmed-article:7208146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7208146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7208146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7208146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7208146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7208146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7208146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7208146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7208146pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7208146pubmed:statusMEDLINElld:pubmed
pubmed-article:7208146pubmed:monthDeclld:pubmed
pubmed-article:7208146pubmed:issn0031-3998lld:pubmed
pubmed-article:7208146pubmed:authorpubmed-author:WalserMMlld:pubmed
pubmed-article:7208146pubmed:authorpubmed-author:BrusilowS WSWlld:pubmed
pubmed-article:7208146pubmed:authorpubmed-author:BatshawM LMLlld:pubmed
pubmed-article:7208146pubmed:issnTypePrintlld:pubmed
pubmed-article:7208146pubmed:volume14lld:pubmed
pubmed-article:7208146pubmed:ownerNLMlld:pubmed
pubmed-article:7208146pubmed:authorsCompleteYlld:pubmed
pubmed-article:7208146pubmed:pagination1316-9lld:pubmed
pubmed-article:7208146pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:meshHeadingpubmed-meshheading:7208146-...lld:pubmed
pubmed-article:7208146pubmed:year1980lld:pubmed
pubmed-article:7208146pubmed:articleTitlePlasma alpha-ketoglutarate in urea cycle enzymopathies and its role as a harbinger of hyperammonemic coma.lld:pubmed
pubmed-article:7208146pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7208146pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7208146pubmed:publicationTypeCase Reportslld:pubmed